Areata Alopecia research hub

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

This study is looking at a medicine called baricitinib for children aged 6 to 17 with severe alopecia areata, a condition causing hair loss. It aims to see if the medicine is safe and helps hair grow back. The study will compare baricitinib to a dummy medicine.